Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Chan

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
European Heart Journal. Digital Health|November 21, 2025
Deep learning-based quantification of epicardial adipose tissue volume from non-contrast computed tomography images: a multi-centre studyShuang Leng, Nicholas Cheng, Eddy Tan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2021
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLDGrace En Hui Lim, Ansel Tang, Cheng Han Ng, et al.
Hepatology (Baltimore, Md.)|January 6, 2022
Placebo effect on progression and regression in NASH: Evidence from a meta-analysisCheng Han Ng, Jieling Xiao, Wen Hui Lim, et al.
Hepatology International|March 23, 2022
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysisJie Ning Yong, Cheng Han Ng, Chloe Wen-Min Lee, et al.
Obesity (Silver Spring, Md.)|February 7, 2023
A two-decade population-based study on the effect of hypertension in the general population with obesity in the United StatesGwyneth Kong, Yip H Chin, Jieyu Lim, et al.
Clinical and Molecular Hepatology|May 19, 2022
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver diseaseCheng Han Ng, Kai En Chan, Yip Han Chin, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2022
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 IndividualsKai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 1, 2022
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 IndividualsJingxuan Quek, Cheng Han Ng, Ansel Shao Pin Tang, et al.
Frontiers in Cardiovascular Medicine|August 25, 2022
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortalityCheng Han Ng, Zhen Yu Wong, Nicholas W S Chew, et al.
Frontiers in Medicine|May 11, 2023
General Public's knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study populationVickram Vijay Anand, Rachel Sze Jen Goh, Benjamin Nah, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
European Heart Journal. Digital Health|November 21, 2025
Deep learning-based quantification of epicardial adipose tissue volume from non-contrast computed tomography images: a multi-centre studyShuang Leng, Nicholas Cheng, Eddy Tan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2021
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLDGrace En Hui Lim, Ansel Tang, Cheng Han Ng, et al.
Hepatology (Baltimore, Md.)|January 6, 2022
Placebo effect on progression and regression in NASH: Evidence from a meta-analysisCheng Han Ng, Jieling Xiao, Wen Hui Lim, et al.
Hepatology International|March 23, 2022
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysisJie Ning Yong, Cheng Han Ng, Chloe Wen-Min Lee, et al.
Obesity (Silver Spring, Md.)|February 7, 2023
A two-decade population-based study on the effect of hypertension in the general population with obesity in the United StatesGwyneth Kong, Yip H Chin, Jieyu Lim, et al.
Clinical and Molecular Hepatology|May 19, 2022
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver diseaseCheng Han Ng, Kai En Chan, Yip Han Chin, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2022
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 IndividualsKai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 1, 2022
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 IndividualsJingxuan Quek, Cheng Han Ng, Ansel Shao Pin Tang, et al.
Frontiers in Cardiovascular Medicine|August 25, 2022
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortalityCheng Han Ng, Zhen Yu Wong, Nicholas W S Chew, et al.
Frontiers in Medicine|May 11, 2023
General Public's knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study populationVickram Vijay Anand, Rachel Sze Jen Goh, Benjamin Nah, et al.
Pageof 11